Kevin Brown, MD
Enriched profileSenior Investigator, Head of the Kevin Brown Laboratory · National Cancer Institute
Kevin Brown is Senior Investigator, Head of the Kevin Brown Laboratory at National Cancer Institute. OpenAlex indexes 463 publications with 55,052 citations (h-index 87); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Kevin M. Brown, MD, is Senior Investigator, Head of the Kevin Brown Laboratory at National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG), Laboratory of Translational Genomics. The public record shows 463 publications with 55,052 citations (h-index 87), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Melanoma and MAPK Pathways, Systemic Sclerosis and Related Diseases. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 16 companies, 3 NIH-funded awards (1999–2017).
- Most recent indexed publication: 2026 · British journal of cancer
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 217.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
Sponsor: University of North Carolina, Chapel Hill
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Sponsor: Duke University
Industry payments
Updated 27 Aug 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202520 payments$40,270openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year20256 payments
- ABBVIE INC.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Pyridone62.2%Pirfenidone100%Part D<11 patientsKinase inhibitor37.8%Ofev100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 1999–2017 per NIH RePORTER. The latest:
- Methods and Strategies for Chemical Synthesis
Trustees of Indiana University
FY2026$567,649R35GM131755 - Efficacy of targeting GAPM3 to block acute and chronic Toxoplasma gondii infections
University of Oklahoma Hlth Sciences Ctr
FY2026$463,290R01AI198553 - Methods and Strategies for Chemical Synthesis
Trustees of Indiana University
FY2025$569,676R35GM131755
Congress activity
Updated 27 Aug 2026
20 congress contributions (2011–2024) across AACE, AACR, ASCO, ASH, SABCS per OpenAlex. The most recent:
- Abstract LB226: Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition
AACR Annual Meeting
AACR2024Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- GWAS meta-analysis provides new insights into uveal melanoma risk.
British journal of cancer
Article2026 - A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.
Research square
Article2026 - A large-scale genome-wide association meta-analysis for nevus count provides direct insights into the genetics of melanoma.
Nature communications
Meta-analysis2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis4,631 citations2014
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- X / Twitter
twitter.com/kbrowngenetics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗ - LinkedIn
linkedin.com/in/kevin-brown-19063543
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Dceg.cancer.gov
Twitter/X: @kbrowngenetics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dceg.cancer.gov ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Editorial & leadership roles
journal and society appointments- Member
International Melanoma Genetics Consortium (GenoMEL)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric J. Feuer
National Cancer Institute
Mirella Marino
National Cancer Institute
James J. Goedert
National Cancer Institute
Francesco Facciolo
National Cancer Institute